INTERVIEW: Dong-A Seeks Partners For Global Expansion Push

With a goal of becoming a truly global biopharma firm, Dong-A is now stepping up its R&D efforts like many other leading South Korean pharma companies. In an interview with PharmAsia News, a senior company executive talks about strategies for overseas business development including plans for biosimilars and original new drug candidates.